Drug · DIN 02403897
NEUPRO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 19, 2013; first marketed December 19, 2013.
- Drug Identification Number (DIN)
- 02403897
- Company (DIN owner)
- Ucb Canada IncOakville, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Patch
- Route
- Transdermal
- Therapeutic class (ATC)
- Rotigotine N04BC09
- Class
- Human
- Record last updated
- June 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ROTIGOTINE | 1 MG | 24 HOUR |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 21, 2013: NOC 14234New Drug Submission (NDS)
Other DINs named NEUPRO
- DIN 02403900 · Marketed
- DIN 02403919 · Marketed
- DIN 02403927 · Marketed
- DIN 02403935 · Marketed
- DIN 02403943 · Marketed